ArriVent BioPharma, Inc. Common Stock (AVBP)
NASDAQ·Healthcare·Biotechnology
$29.90
-1.43%
Mkt Cap $1.37B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | — | — | — | -$0.87 | -$0.78 | +10.34% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.78 | -$0.83 | -6.41% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.70 | -$0.90 | -28.57% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.66 | -$1.90 | -187.88% | — | — |
| Q1 2025 Mar 3, 2025 | — | — | — | -$0.78 | -$0.60 | +23.08% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.82 | -$0.61 | +25.61% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.65 | -$0.65 | +0.00% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.84 | -$0.70 | +16.67% | — | — |
| Q1 2024 Jan 26, 2024 | — | — | — | -$1.10 | -$0.70 | +36.36% | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.43 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.64 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.36 | — | — | — |
| Q4 2022 Dec 30, 2022 | — | — | — | — | -$0.31 | — | — | — |
| Q3 2022 Sep 29, 2022 | — | — | — | — | -$0.35 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$5.76 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$5.76 | — | — | — |